{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:59Z","timestamp":1707524099591},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,10]]},"DOI":"10.7759\/cureus.10356","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T14:05:25Z","timestamp":1599746725000},"source":"Crossref","is-referenced-by-count":0,"title":["Increased Risk of Cutaneous Diseases in Multiple Myeloma Patients"],"prefix":"10.7759","author":[{"given":"Talayesa","family":"Buntinx-Krieg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn Z","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Key statistics about multiple myeloma. (2020). Accessed. January 1, 2020: https:\/\/www.cancer.org\/cancer\/multiple-myeloma\/about\/key-statistics.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.08.054","article-title":"Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: a case series from korea","volume":"78","author":"Woo YR","year":"2018","unstructured":"Woo YR, Kim JS, Lim JH, et al.. Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: a case series from korea. J Am Acad Dermatol. 2018, 78:471-478. 10.1016\/j.jaad.2017.08.054","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13847","article-title":"Monoclonal gammopathy of cutaneous significance: review of a relevant concept","volume":"31","author":"Lipsker D","year":"2017","unstructured":"Lipsker D. Monoclonal gammopathy of cutaneous significance: review of a relevant concept. J Eur Acad Dermatol Venereol. 2017, 31:45-52. 10.1111\/jdv.13847","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.193682","article-title":"Cutaneous manifestations of multiple myeloma","volume":"61","author":"Behera B","year":"2016","unstructured":"Behera B, Pattnaik M, Sahu B, Mohanty P, Jena S, Mohapatra L. Cutaneous manifestations of multiple myeloma. Indian J Dermatol. 2016, 61:668-671. 10.4103\/0019-5154.193682","journal-title":"Indian J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw606","article-title":"Second primary malignancies in multiple myeloma: an overview and IMWG consensus","volume":"28","author":"Musto P","year":"2017","unstructured":"Musto P, Anderson KC, Attal M, et al.. Second primary malignancies in multiple myeloma: an overview and IMWG consensus. Ann Oncol. 2017, 28:228-245. 10.1093\/annonc\/mdw606","journal-title":"Ann Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0132-1","article-title":"Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry","volume":"10","author":"Baughn LB","year":"2018","unstructured":"Baughn LB, Pearce K, Larson D, et al.. Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry. Blood Cancer J. 2018, 10:96. 10.1038\/s41408-018-0132-1","journal-title":"Blood Cancer J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12748","article-title":"Risk of skin cancer in multiple myeloma patients: a retrospective cohort study","volume":"97","author":"Robinson AA","year":"2016","unstructured":"Robinson AA, Wang J, Vardanyan S, et al.. Risk of skin cancer in multiple myeloma patients: a retrospective cohort study. Eur J Haematol. 2016, 97:439-444. 10.1111\/ejh.12748","journal-title":"Eur J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/31905-increased-risk-of-cutaneous-diseases-in-multiple-myeloma-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:17Z","timestamp":1707506777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/31905-increased-risk-of-cutaneous-diseases-in-multiple-myeloma-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.10356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,10]]}}}